141 related articles for article (PubMed ID: 10815803)
1. The secreted glycoprotein CREG enhances differentiation of NTERA-2 human embryonal carcinoma cells.
Veal E; Groisman R; Eisenstein M; Gill G
Oncogene; 2000 Apr; 19(17):2120-8. PubMed ID: 10815803
[TBL] [Abstract][Full Text] [Related]
2. Human Wnt-13 is developmentally regulated during the differentiation of NTERA-2 pluripotent human embryonal carcinoma cells.
Wakeman JA; Walsh J; Andrews PW
Oncogene; 1998 Jul; 17(2):179-86. PubMed ID: 9674702
[TBL] [Abstract][Full Text] [Related]
3. The secreted glycoprotein CREG inhibits cell growth dependent on the mannose-6-phosphate/insulin-like growth factor II receptor.
Di Bacco A; Gill G
Oncogene; 2003 Aug; 22(35):5436-45. PubMed ID: 12934103
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of novel members of the CREG family, putative secreted glycoproteins expressed specifically in brain.
Kunita R; Otomo A; Ikeda JE
Genomics; 2002 Nov; 80(5):456-60. PubMed ID: 12408961
[TBL] [Abstract][Full Text] [Related]
5. The CDK inhibitor p27 enhances neural differentiation in pluripotent NTERA2 human EC cells, but does not permit differentiation of 2102Ep nullipotent human EC cells.
Bahrami AR; Matin MM; Andrews PW
Mech Dev; 2005 Sep; 122(9):1034-42. PubMed ID: 16023837
[TBL] [Abstract][Full Text] [Related]
6. Retinoic acid induces neuronal differentiation of embryonal carcinoma cells by reducing proteasome-dependent proteolysis of the cyclin-dependent inhibitor p27.
Baldassarre G; Boccia A; Bruni P; Sandomenico C; Barone MV; Pepe S; Angrisano T; Belletti B; Motti ML; Fusco A; Viglietto G
Cell Growth Differ; 2000 Oct; 11(10):517-26. PubMed ID: 11063125
[TBL] [Abstract][Full Text] [Related]
7. Role of retinoic acid in the differentiation of embryonal carcinoma and embryonic stem cells.
Soprano DR; Teets BW; Soprano KJ
Vitam Horm; 2007; 75():69-95. PubMed ID: 17368312
[TBL] [Abstract][Full Text] [Related]
8. [Expression of cellular repressor of E1A-stimulated genes in vascular smooth muscle cells of different phenotypes].
Han YL; Liu HW; Kang J; Yan CH; Wang XZ; Zhao LY; Li SH
Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(1):49-53. PubMed ID: 15808078
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of the mouse and human Thy-1 gene in embryonal carcinoma cells.
Malý P; Králová J; Dráber P
Int J Dev Biol; 1992 Dec; 36(4):567-71. PubMed ID: 1363523
[TBL] [Abstract][Full Text] [Related]
10. Differentiation of human embryonal carcinomas in vitro and in vivo reveals expression profiles relevant to normal development.
Skotheim RI; Lind GE; Monni O; Nesland JM; Abeler VM; Fosså SD; Duale N; Brunborg G; Kallioniemi O; Andrews PW; Lothe RA
Cancer Res; 2005 Jul; 65(13):5588-98. PubMed ID: 15994931
[TBL] [Abstract][Full Text] [Related]
11. Curcumin-induced differentiation of mouse embryonal carcinoma PCC4 cells.
Batth BK; Tripathi R; Srinivas UK
Differentiation; 2001 Sep; 68(2-3):133-40. PubMed ID: 11686235
[TBL] [Abstract][Full Text] [Related]
12. A putative G-protein-coupled receptor, H218, is down-regulated during the retinoic acid-induced differentiation of F9 embryonal carcinoma cells.
Li Y; MacLennan AJ; Rogers MB
Exp Cell Res; 1998 Mar; 239(2):320-5. PubMed ID: 9521849
[TBL] [Abstract][Full Text] [Related]
13. Isolation of human embryonal carcinoma stem cells by immunomagnetic sorting.
Przyborski SA
Stem Cells; 2001; 19(6):500-4. PubMed ID: 11713341
[TBL] [Abstract][Full Text] [Related]
14. Telomerase activity is repressed during differentiation of maturation-sensitive but not resistant human tumor cell lines.
Albanell J; Han W; Mellado B; Gunawardane R; Scher HI; Dmitrovsky E; Moore MA
Cancer Res; 1996 Apr; 56(7):1503-8. PubMed ID: 8603393
[TBL] [Abstract][Full Text] [Related]
15. Differentiation and proliferation in mouse embryonal carcinoma cells.
Sleigh MJ
Bioessays; 1992 Nov; 14(11):769-75. PubMed ID: 1365890
[TBL] [Abstract][Full Text] [Related]
16. CREG promotes a mature smooth muscle cell phenotype and reduces neointimal formation in balloon-injured rat carotid artery.
Han Y; Deng J; Guo L; Yan C; Liang M; Kang J; Liu H; Graham AM; Li S
Cardiovasc Res; 2008 Jun; 78(3):597-604. PubMed ID: 18267954
[TBL] [Abstract][Full Text] [Related]
17. Sox6 overexpression causes cellular aggregation and the neuronal differentiation of P19 embryonic carcinoma cells in the absence of retinoic acid.
Hamada-Kanazawa M; Ishikawa K; Nomoto K; Uozumi T; Kawai Y; Narahara M; Miyake M
FEBS Lett; 2004 Feb; 560(1-3):192-8. PubMed ID: 14988021
[TBL] [Abstract][Full Text] [Related]
18. Constitutive gene expression predisposes morphogen-mediated cell fate responses of NT2/D1 and 27X-1 human embryonal carcinoma cells.
Chadalavada RS; Korkola JE; Houldsworth J; Olshen AB; Bosl GJ; Studer L; Chaganti RS
Stem Cells; 2007 Mar; 25(3):771-8. PubMed ID: 17138961
[TBL] [Abstract][Full Text] [Related]
19. Classification of neural differentiation-associated genes in P19 embryonal carcinoma cells by their expression patterns induced after cell aggregation and/or retinoic acid treatment.
Teramoto S; Kihara-Negishi F; Sakurai T; Yamada T; Hashimoto-Tamaoki T; Tamura S; Kohno S; Oikawa T
Oncol Rep; 2005 Nov; 14(5):1231-8. PubMed ID: 16211290
[TBL] [Abstract][Full Text] [Related]
20. The TRA-1-60 and TRA-1-81 human pluripotent stem cell markers are expressed on podocalyxin in embryonal carcinoma.
Schopperle WM; DeWolf WC
Stem Cells; 2007 Mar; 25(3):723-30. PubMed ID: 17124010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
